papillary thyroid cancer semaglutide Can a patient with carcinoma who is post‑thyroidectomy, on stable levothyroxine replacement and has no residual disease safely use (generic: semaglutide)? Thyroid cancer survivor wondering about
Description
Wegovy is now available in pill form
As the use of GLP-1 therapies increase, it will be important to recognize and manage unique adverse events that may arise.
Today, the FDA is announcing its intent to take decisive steps to restrict GLP-1 active pharmaceutical ingredients intended for use in non-FDA-approved compounded drugs that are being mass-marketed by companies including Hims &
U.S.-licensed providers review in under 24 hours no calls, no video visits
Expert guidance on causes, frequency, and when to contact your doctor.
